Desalting Exchange Market Report by Manufacturers, Opportunities, Challenges, Drivers, Growth, Countries, Revenue, And Forecast To 2023

Desalting Exchange Market Report by Manufacturers, Opportunities, Challenges, Drivers, Growth, Countries, Revenue, And Forecast To 2023

Desalting and Buffer Exchange Market Overview:

The Desalting and Buffer Exchange Market is expected to reach USD 1,094.8 million by 2023 from USD 679.8 million in 2018, at a CAGR of 10.0%. Increasing demand for mAbs, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies, and a growing focus on proteomic and genomic research drive the growth of the desalting and buffer exchange market.

Major players operating in the desalting and buffer exchange market are Thermo Fisher Scientific (US), Merck (US), GE Healthcare (US), Danaher (US), and Sartorius (Germany). The overall desalting and buffer exchange market is expected to reach USD 1,094.8 million by 2023 from USD 679.8 million in 2018, at a CAGR of 10.0%. Increasing demand for mAbs, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies, and a growing focus on proteomic and genomic research are the major factors driving the growth of the desalting and buffer exchange market.

Most companies focus on geographic expansions and acquisitions to compete in the market. The companies also focus on increasing their presence in high-growth markets through establishing their manufacturing facilities and distribution centers in developing market. Merck (US) and Sartorius (Germany) focus on geographic expansion to expand their presence in the market. However, Danaher (US) and Avantor (US) focus on acquisitions to strengthen their position in the market

Request For Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=3721738

Research Methodology
Both, top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, presentations, websites, and press releases of top players, news articles, journals; and paid databases ,white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as Clinical Proteomic Tumor Analysis Consortium (CPTAC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), US FDA, Chromatographic Society (ChromSoc), European Society for Separation Science. Whereas, primary research included extensive interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Download PDF:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3721738

Market Segmentation:

Based on technique, the filtration segment is expected to account for the largest share of the market in 2018

On the basis of technique, the market is broadly segmented into filtration, chromatography, and precipitation. The filtration market is further segmented into ultrafiltration and dialysis techniques. The chromatography market is further segmented into size exclusion chromatography and other chromatography techniques. The filtration segment is expected to account for the largest share of the global desalting and buffer exchange market in 2018. The large share of this segment is attributed to the increased production of biologics and growth of proteomics and genomics research.
Based on application, the bioprocess segment is expected to account for the largest share of the market in 2018
On the basis of application, the market is broadly segmented into bioprocess and diagnostics. The bioprocess application segment is expected to account for the largest share of the global desalting and buffer exchange market in 2018. The large share of this segment is attributed to the growing demand for biopharmaceuticals and monoclonal antibodies, as well as increasing R&D expenditure by biopharmaceutical companies.
North America is expected to dominate the market in 2018
In 2018, North America is expected to account for the largest share of the global desalting and buffer exchange market. The large share of this regional segment is attributed to the increasing demand for biopharmaceuticals, rising R&D expenditure by biopharmaceutical companies, and growing research activities in the field of genomics and proteomics.
Detailed Information: https://www.marketsandmarkets.com/Market-Reports/desalting-buffer-exchange-market-3721738.html

Key Players:

In the desalting and buffer exchange market are Thermo Fisher Scientific (US), Merck (US), GE Healthcare (US), Danaher (US), and Sartorius (Germany).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com